Investigational Site Number 076013

São Paulo 08270-070

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Multiple Sclerosis Relapse, Prostate Cancer

Studies at this site

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer — Completed
• Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta — Stopped early